|
|
Volumn 38, Issue 3, 2010, Pages 227-228
|
|
Resistant herpes simplex keratitis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
ALPHA INTERFERON;
ANTIVIRUS AGENT;
CIDOFOVIR;
FAMCICLOVIR;
FOSCARNET;
GANCICLOVIR;
TRIFLURIDINE;
VALACICLOVIR;
VIDARABINE;
ANTIVIRAL THERAPY;
ATOPY;
CREATININE BLOOD LEVEL;
DISEASE RESISTANCE;
DOSE RESPONSE;
DRUG ADMINISTRATION ROUTE;
DRUG COST;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG MANUFACTURE;
DRUG SENSITIVITY;
DRUG SUBSTITUTION;
DRUG TREATMENT FAILURE;
EDITORIAL;
GEL;
HERPES SIMPLEX KERATITIS;
HOSPITALIZATION;
HUMAN;
IMMUNOCOMPROMISED PATIENT;
NEPHROTOXICITY;
OINTMENT;
PATIENT ATTITUDE;
PHARMACY;
ROSACEA;
TREATMENT WITHDRAWAL;
ULCER;
URINARY TRACT DISEASE;
ACYCLOVIR;
ANTIVIRAL AGENTS;
CORNEAL DISEASES;
DRUG RESISTANCE, VIRAL;
FOSCARNET;
HUMANS;
KERATITIS, HERPETIC;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 77953203334
PISSN: 14426404
EISSN: 14429071
Source Type: Journal
DOI: 10.1111/j.1442-9071.2010.02250.x Document Type: Editorial |
|
Times cited : (7)
|
|
References (5)
|
